Novo discloses Pfizer's patent suit; Shareholders sue St. Jude;

 @FierceMedDev: Why Oct. 4 is a landmark day for the U.S. device industry? hint: bring a scalpel rather than a meat axe. Article | Follow @FierceMedDev

> Danish drugmaker Novo Nordisk said Monday U.S. rival Pfizer had in July filed a lawsuit against it in a British court over a patent related to an injection pen under development. News

> Shareholders of St. Jude Medical want corporate executives held responsible for the company's $3.7 million settlement with the government over allegations of False Claims Act violations and rampant kickback schemes. Report

> A drug-coated stent from Cook Medical, the maker of devices for minimally invasive medical procedures, was more effective than standard therapy for patients with blockages in an upper-leg artery, a study found. Item

> Treating hospital patients with thigh-length surgical stockings, rather than knee-high socks, can reduce the chance of developing life threatening blood clots by 30 percent, according to groundbreaking new research from the University of Sydney. Report

> Burg Simpson Eldredge Hersh & Jardine, P.C., one of the nations' leading plaintiff litigation law firms, has filed a class action lawsuit in Ohio against DePuy Orthopaedics on behalf of all United States citizens who received an implant of the ASR XL Acetabular System hip replacement. Burg Simpson Eldredge Hersh & Jardine release

> ProUroCare Medical has announced the signing of an agreement for $3.125 million in equity financing with Seaside 88 LP of Juno Beach, FL.  The proceeds of the financing will be used to expand the company's product portfolio and to support scale-up activities associated with final preparation, manufacturing and eventual marketing of the ProUroScan prostate imaging system following FDA clearance. ProUroCare release

> ECI Biotech, a premier developer of diagnostic sensors that will ultimately transform the way pathogens are detected in wound care and Systagenix, a leading medical device company specializing in cutting-edge chronic wound care solutions, today announced an exciting new partnership and agreement in producing affordable diagnostic sensors to aid in the better diagnosis and treatment of chronic wound infections. ECI release

> Engineers funded by the National Space Biomedical Research Institute (NSBRI) are developing a system that will provide an accurate patient history, assist in treatment, and help astronauts be more efficient when providing medical care. Even though the integrated system is being developed for use in space, it can be used in many different locations, such as the emergency room, on the battlefield or at an accident scene. NSBRI release

> CareFusion has entered into an agreement with Healthpoint to market and sell innovative surgical scrub solutions, including Surgicept Waterless Surgical Hand Scrub, Triseptin Water-Aided Surgical Scrub and Triseptin Hand and Body Antiseptic. CareFusion release

> Researchers are working to recover normal movement and behavior within patients who have suffered brain damage by creating microelectronic circuitry that will promote the reconnection of neurons and growth of axons. Story

And Finally... Frank Reynolds is not afraid of the bold pronouncement. While most people who suffer a traumatic spinal cord injury never recover their normal functioning, Reynolds has written that his company's medical device will "restore 80 percent of the patient's normal functioning." In the company's early experiments with paralyzed primates, Reynolds has said, "100 percent of our monkeys have gotten up and walked in just about three weeks." Article